Inventor · disambiguated record
Eva Czirr
Also filed as: CZIRR EVA
8 granted patents·6 pending applications·27 citations·filing 2018–2024
82Inventor score
Files withALKAHEST INC14
Top patents by PatentIndex Score
14 records- 0194US10357513B2Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma productsALKAHEST INC·Filed 2018·Granted Jul 23, 2019·17 cites·10 claims
- 0287US10874692B2Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma productsALKAHEST INC·Filed 2019·Granted Dec 29, 2020·6 cites·13 claims
- 0384US11957671B2Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseasesALKAHEST INC·Filed 2022·Granted Apr 16, 2024·1 cites·13 claims
- 0484US11413308B2Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma productsALKAHEST INC·Filed 2020·Granted Aug 16, 2022·1 cites·19 claims
- 0581US11426399B2Treatment of aging-associated disease with modulators of leukotriene A4 hydrolaseALKAHEST INC·Filed 2019·Granted Aug 30, 2022·1 cites·17 claims
- 0673US11040068B2Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma productsALKAHEST INC·Filed 2019·Granted Jun 22, 2021·1 cites·14 claims
- 0769US2022226304A1Treatment of Aging-Associated Disease with Modulators of Leukotriene A4 HydrolaseALKAHEST INC·Filed 2022·Application pending·0 cites
- 0867US11344542B2Treatment of aging-associated disease with modulators of leukotriene A4 hydrolaseALKAHEST INC·Filed 2020·Granted May 31, 2022·0 cites·3 claims
- 0966US12496296B2Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseasesALKAHEST INC·Filed 2024·Granted Dec 16, 2025·0 cites·20 claims
- 1066US2024076369A1Methods and Compositions for Treating Aging-Associated Impairments with Trefoil Factor Family Member 2 ModulatorsALKAHEST INC·Filed 2022·Application pending·0 cites
- 1161US2021301013A1Methods and Compositions for Treating Aging-Associated Impairments with Trefoil Factor Family Member 2 ModulatorsALKAHEST INC·Filed 2021·Application pending·0 cites
- 1260US2021315932A1Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma ProductsALKAHEST INC·Filed 2021·Application pending·0 cites
- 1357US2023399380A1Methods and Compositions for Treating Aging-Associated Impairments with TIMP-2 Recombinant ProteinsALKAHEST INC·Filed 2023·Application pending·0 cites
- 1452US2021171626A1Methods and Compositions for Treating Aging-Associated Impairments with Trefoil Factor Family Member 2 ModulatorsALKAHEST INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →